BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17606448)

  • 1. An international study to standardize the detection and quantitation of BCR-ABL transcripts from stabilized peripheral blood preparations by quantitative RT-PCR.
    Müller MC; Saglio G; Lin F; Pfeifer H; Press RD; Tubbs RR; Paschka P; Gottardi E; O'Brien SG; Ottmann OG; Stockinger H; Wieczorek L; Merx K; König H; Schwindel U; Hehlmann R; Hochhaus A
    Haematologica; 2007 Jul; 92(7):970-3. PubMed ID: 17606448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratories.
    Müller MC; Erben P; Saglio G; Gottardi E; Nyvold CG; Schenk T; Ernst T; Lauber S; Kruth J; Hehlmann R; Hochhaus A;
    Leukemia; 2008 Jan; 22(1):96-102. PubMed ID: 17943168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of minimal residual disease in patients with e1a2 BCR-ABL-positive acute lymphoblastic leukemia using a real-time RT-PCR assay.
    Yokota H; Tsuno NH; Tanaka Y; Fukui T; Kitamura K; Hirai H; Osumi K; Itou N; Satoh H; Okabe M; Nakahara K
    Leukemia; 2002 Jun; 16(6):1167-75. PubMed ID: 12040449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Standardization of quantitative detection of BCR-ABL gene expression by RQ-PCR in patients with chronic myeloid leukemia in cooperation with European Leukemia Net].
    Sacha T; Zawada M; Czekalska S; Florek I; Mueller M; Gniot M; Jaźwiec B; Kyrcz-Krzemień S; Leszczyńska A; Lewandowski K; Matiakowska K; Solarska I; Stokłosa T; Skotnicki AB
    Przegl Lek; 2010; 67(7):454-9. PubMed ID: 21387754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LightCycler technology for the quantitation of bcr/abl fusion transcripts.
    Kreuzer KA; Lass U; Bohn A; Landt O; Schmidt CA
    Cancer Res; 1999 Jul; 59(13):3171-4. PubMed ID: 10397261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia.
    Yaghmaie M; Ghaffari SH; Ghavamzadeh A; Alimoghaddam K; Jahani M; Mousavi SA; Irvani M; Bahar B; Bibordi I
    Arch Iran Med; 2008 May; 11(3):247-51. PubMed ID: 18426313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid quantitative detection of BCR-ABL transcripts in chronic myeloid leukemia patients by real-time reverse transcriptase polymerase-chain reaction using fluorescently labeled probes.
    Bolufer P; Sanz GF; Barragán E; Sanz MA; Cervera J; Lerma E; Senent L; Moreno I; Planelles MD
    Haematologica; 2000 Dec; 85(12):1248-54. PubMed ID: 11114130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of BCR-ABL fusion transcripts in Sudanese patients with chronic myeloid leukemia using real-time reverse transcription-polymerase chain reaction.
    Muddathir AM; Kordofani AA; Fadl-Elmula IM
    Saudi Med J; 2013 Jan; 34(1):29-33. PubMed ID: 23299156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of molecular variants of BCR-ABL gene in bone marrow and blood of patients with chronic myeloid leukemia by reverse-transcriptase polymerase chain reaction (RT-PCR).
    Udomsakdi-Auewarakul C; U-Pratya Y; Boonmoh S; Vatanavicharn S
    J Med Assoc Thai; 2000 Aug; 83(8):928-35. PubMed ID: 10998848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative monitoring of BCR--ABL transcript--suggestion of a simplified approach considering inaccuracy of measurement and calibration.
    Röthlisberger B; Herklotz R; Hergersberg M; Stricker C; Bargetzi M; Huber AR
    Leuk Lymphoma; 2004 Jun; 45(6):1119-21. PubMed ID: 15359990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of BCR-ABL transcript types in Korean CML patients using a newly developed multiplex RT-PCR.
    Goh HG; Hwang JY; Kim SH; Lee YH; Kim YL; Kim DW
    Transl Res; 2006 Nov; 148(5):249-56. PubMed ID: 17145570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA.
    White HE; Matejtschuk P; Rigsby P; Gabert J; Lin F; Lynn Wang Y; Branford S; Müller MC; Beaufils N; Beillard E; Colomer D; Dvorakova D; Ehrencrona H; Goh HG; El Housni H; Jones D; Kairisto V; Kamel-Reid S; Kim DW; Langabeer S; Ma ES; Press RD; Romeo G; Wang L; Zoi K; Hughes T; Saglio G; Hochhaus A; Goldman JM; Metcalfe P; Cross NC
    Blood; 2010 Nov; 116(22):e111-7. PubMed ID: 20720184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of molecular monitoring of residual disease in leukemias by bedside RNA stabilization.
    Müller MC; Merx K; Weisser A; Kreil S; Lahaye T; Hehlmann R; Hochhaus A
    Leukemia; 2002 Dec; 16(12):2395-9. PubMed ID: 12454744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of bcr/abl mRNA expression level in leukemia cells by FQ-RT-PCR.
    Gao J; Tong M; He Y; Nie C; Zhou Y
    Zhonghua Xue Ye Xue Za Zhi; 2002 Jul; 23(7):363-6. PubMed ID: 12411054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of HLA Class I and Class II genes with bcr-abl transcripts in leukemia patients with t(9;22) (q34;q11).
    Mundhada S; Luthra R; Cano P
    BMC Cancer; 2004 Jun; 4():25. PubMed ID: 15202948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardization of preanalytical factors for minimal residual disease analysis in chronic myelogenous leukemia.
    Müller MC; Hördt T; Paschka P; Merx K; La Rosée P; Hehlmann R; Hochhaus A
    Acta Haematol; 2004; 112(1-2):30-3. PubMed ID: 15179002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple multiplex RT-PCR for identifying common fusion BCR-ABL transcript types and evaluation of molecular response of the a2b2 and a2b3 transcripts to Imatinib resistance in north Indian chronic myeloid leukemia patients.
    Mir R; Ahmad I; Javid J; Zuberi M; Yadav P; Shazia R; Masroor M; Guru S; Ray PC; Gupta N; Saxena A
    Indian J Cancer; 2015; 52(3):314-8. PubMed ID: 26905124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of bcr-abl-positive leukemias.
    Cox MC; Maffei L; Buffolino S; Del Poeta G; Venditti A; Cantonetti M; Aronica G; Aquilina P; Masi M; Amadori S
    Am J Clin Pathol; 1998 Jan; 109(1):24-31. PubMed ID: 9426514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of residual disease in Philadelphia-positive acute lymphoblastic leukemia: comparison of blood and bone marrow.
    van Rhee F; Marks DI; Lin F; Szydlo RM; Hochhaus A; Treleaven J; Delord C; Cross NC; Goldman JM
    Leukemia; 1995 Feb; 9(2):329-35. PubMed ID: 7869772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suitability of the PAXgene system to stabilize bone marrow RNA in imatinib-resistant patients with chronic myeloid leukemia.
    Ernst T; Hoffmann J; Erben P; Hehlmann R; Hochhaus A; Müller MC
    Clin Chem Lab Med; 2008; 46(3):318-22. PubMed ID: 18303987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.